Highlights and Quick Summary
- Assets Growth for the quarter ending September 30, 2022 was 1.1 (a 30.99% increase compared to previous quarter)
- Year-over-year quarterly Assets Growth increased by 45.52%
- Annual Assets Growth for 2021 was 0.76 (a -16.75% decrease from previous year)
- Annual Assets Growth for 2020 was 0.91 (a 369.59% increase from previous year)
- Annual Assets Growth for 2019 was 0.19 (a -209.93% decrease from previous year)
Visit stockrow.com/BCRX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Assets Growth of BioCryst Pharmaceuticals, Inc.
Most recent Assets Growthof BCRX including historical data for past 10 years.Interactive Chart of Assets Growth of BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. Assets Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | 1.1 | 0.84 | 0.86 | – |
| 2021 | 0.76 | 0.51 | 0.29 | 1.08 | 0.76 |
| 2020 | 0.91 | 0.95 | 0.85 | -0.04 | 0.91 |
| 2019 | 0.19 | -0.46 | -0.15 | -0.08 | 0.19 |
| 2018 | -0.18 | -0.12 | 0.2 | 0.2 | -0.18 |
| 2017 | 0.98 | 1.09 | 0.38 | 0.26 | 0.98 |
| 2016 | -0.27 | -0.34 | -0.45 | -0.21 | -0.27 |
| 2015 | -0.11 | 0.01 | 0.06 | 1.99 | -0.11 |
| 2014 | 1.8 | 1.58 | 2.56 | -0.07 | 1.8 |
| 2013 | -0.15 | -0.17 | -0.48 | -0.41 | -0.15 |
| 2012 | -0.3 | -0.31 | -0.3 | -0.35 | -0.3 |
Business Profile of BioCryst Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology